BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2344682)

  • 1. Hemodynamic mechanisms of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina.
    Yokota M; Miyahara T; Iwase M; Watanabe M; Matsunami T; Kamihara S; Koide M; Saito H; Takeuchi J
    Circulation; 1990 Jun; 81(6):1887-98. PubMed ID: 2344682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new second generation calcium channel blocker, nilvadipine (FR34235), on exercise-induced hemodynamic changes in stable angina pectoris.
    Yokota M; Koide M; Miyahara T; Kamihara S; Tsunekawa A; Noda S; Sotobata I
    J Am Coll Cardiol; 1987 Oct; 10(4):830-6. PubMed ID: 3655150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects.
    Lam J; Chaitman BR; Crean P; Blum R; Waters DD
    J Am Coll Cardiol; 1985 Aug; 6(2):447-52. PubMed ID: 3894474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nisoldipine on systemic and leg blood flow, oxygen transport and metabolism, and hemodynamics during exercise in effort angina pectoris.
    Ram J; Freedman SB; Ogasawara S; Thomson A; Kelly DT
    Am J Cardiol; 1989 Apr; 63(12):802-6. PubMed ID: 2929436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic mechanisms of the antianginal action of a novel vasodilator FK409 in dynamic exercise-induced angina.
    Yokota M; Matsunami T; Kodama Y; Sobue T; Nishinaka Y; Iwase M; Miyahara T; Koide M; Saito H; Shibata S
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):412-22. PubMed ID: 7681502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
    Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H
    Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antianginal agents on the relationship between rate-pressure product and myocardial oxygen uptake.
    Kodama Y; Yokota M; Miyahara T; Matsunami T; Sobue T; Saito H
    Am Heart J; 1993 Sep; 126(3 Pt 1):587-93. PubMed ID: 8362713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of isosorbide-5-mononitrate on exercise-induced hemodynamic changes in angina pectoris.
    Yokota M; Tsunekawa A; Miyahara T; Kamihara S; Kitamura J; Noda S; Koide M; Tsuzuki M; Sotobata I
    Am J Cardiol; 1986 Jul; 58(1):53-8. PubMed ID: 3728331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris.
    Detry JM; De Coster PM; Renkin J
    Am J Cardiol; 1983 Sep; 52(5):453-7. PubMed ID: 6613867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Responses of plasma eicosanoids and hemodynamics to myocardial ischemia and the salutary effect of calcium entry blocker].
    Takase B
    Nihon Ika Daigaku Zasshi; 1990 Feb; 57(1):42-54. PubMed ID: 2329180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
    Kiowski W; Erne P; Pfisterer M; Mueller J; Buehler FR; Burkart F
    Am J Cardiol; 1987 May; 59(12):1118-25. PubMed ID: 3578053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nisoldipine in the therapy of stable exercise angina: evaluation of its efficacy in ergometric tests compared with propranolol].
    Petretta M; Morgano G; Arrichiello P; Breglio R; Lanzillo T; Mazza F; Bonaduce D
    G Ital Cardiol; 1990 Jun; 20(6):518-25. PubMed ID: 2227221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antianginal effect of calcium antagonists, using nisoldipine as an example].
    Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1984 Aug; 114(33):1126-31. PubMed ID: 6484542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of nisoldipine on dipyridamole-induced myocardial ischemia: correlation with exercise electrocardiography.
    Lattanzi F; Paperini L; Orsini E; Paci AM; Levantesi D; Topi A; Reisenhofer B; Lucarini AR; Squarcini G
    Coron Artery Dis; 1998; 9(4):207-15. PubMed ID: 9649927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina.
    Glasser SP; Ripa S; Garland WT; Weiss R; Nademanee K; Singh S; Bittar N
    J Clin Pharmacol; 1995 Aug; 35(8):780-4. PubMed ID: 8522634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol].
    Mitrovic V; Miskovic A; Straub M; Beckmann K; Thormann J; Pitschner H
    Z Kardiol; 1999 Oct; 88(10):838-49. PubMed ID: 10552188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of calcium antagonists on exercise tests.
    Lai C; Cherchi A; Onnis E; Solinas R; Lai G; Cherchi PA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S55-64. PubMed ID: 1282616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy of nisoldipine, metoprolol, and isosorbide dinitrate in patients with stable exertional angina: a randomized, cross-over, placebo-controlled study.
    Ogawa H; Yasue H; Nakamura N; Fujii H; Miyagi H; Kikuta K
    Int J Cardiol; 1995 Feb; 48(2):131-7. PubMed ID: 7774991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and antiischemic effects of intravenous elgodipine, a new dihydropyridine calcium channel blocker, in patients with chronic stable angina.
    Kuhn A; Carlsson J; Miketic S; Tebbe U
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):595-600. PubMed ID: 8547210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.